Xlife Sciences AG (XLS) — Cash Flow Reinvestment Rate
Latest as of December 2023:
0.24x
Xlife Sciences AG (XLS) has a Cash Flow Reinvestment Rate of 0.24x as of December 2023, reinvesting CHF41.08K (capex CHF41.08K ) from operating cash flow of CHF171.78K. Check Xlife Sciences AG cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.24x
(Capex + Investments) / Operating CF
Total Reinvested
CHF41.08K
Capex + Investments
Operating Cash Flow
CHF171.78K
CHF
Capital Expenditures
CHF41.08K
CHF
Xlife Sciences AG Cash Flow Reinvestment Rate (2023–2023)
Historical reinvestment intensity for Xlife Sciences AG across 1 annual periods. Explore Xlife Sciences AG cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Xlife Sciences AG (2023–2023)
Year-by-year capital reinvestment analysis for Xlife Sciences AG. For live market cap and broader valuation context, see XLS market cap.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 6.14x | CHF1.06 Million | CHF171.78K | CHF41.08K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow